Literature DB >> 28939437

Staphylococcus aureus strategies to evade the host acquired immune response.

Oliver Goldmann1, Eva Medina2.   

Abstract

Staphylococcus aureus poses a significant public-health problem. Infection caused by S. aureus can manifest as acute or long-lasting persistent diseases that are often refractory to antibiotic and are associated with significant morbidity and mortality. To develop more effective strategies for preventing or treating these infections, it is crucial to understand why the immune response is incapable to eradicate the bacterium. When S. aureus first infect the host, there is a robust activation of the host innate immune responses. Generally, S. aureus can survive this initial interaction due to the expression of a wide array of virulence factors that interfere with the host innate immune defenses. After this initial interaction the acquired immune response is the arm of the host defenses that will try to clear the pathogen. However, S. aureus is capable of maintaining infection in the host even in the presence of a robust antigen-specific immune response. Thus, understanding the mechanisms underlying the ability of S. aureus to escape immune surveillance by the acquired immune response will help uncover potentially important targets for the development of immune-based adjunctive therapies and more efficient vaccines. There are several lines of evidence that lead us to believe that S. aureus can directly or indirectly disable the acquired immune response. This review will discuss the different immune evasion strategies used by S. aureus to modulate the different components of the acquired immune defenses.
Copyright © 2017 Elsevier GmbH. All rights reserved.

Entities:  

Keywords:  Acquired immune response; Humoral immune response; Immune dysfunction; Immune evasion; Staphylococcus aureus; T-cell mediated immune response

Mesh:

Substances:

Year:  2017        PMID: 28939437     DOI: 10.1016/j.ijmm.2017.09.013

Source DB:  PubMed          Journal:  Int J Med Microbiol        ISSN: 1438-4221            Impact factor:   3.473


  18 in total

1.  Revisiting Bacterial Interference in the Age of Methicillin-resistant Staphylococcus aureus: Insights Into Staphylococcus aureus Carriage, Pathogenicity and Potential Control.

Authors:  Paul J Planet; Dane Parker; Naomi L Ruff; Henry R Shinefield
Journal:  Pediatr Infect Dis J       Date:  2019-09       Impact factor: 2.129

2.  Immune Response to Persistent Staphyloccocus Aureus Periprosthetic Joint Infection in a Mouse Tibial Implant Model.

Authors:  Upneet K Sokhi; Yunwei Xia; Branden Sosa; Kathleen Turajane; Sita N Nishtala; Tania Pannellini; Mathias P Bostrom; Alberto V Carli; Xu Yang; Lionel B Ivashkiv
Journal:  J Bone Miner Res       Date:  2022-01-03       Impact factor: 6.741

Review 3.  Integrating complex host-pathogen immune environments into S. aureus vaccine studies.

Authors:  Chih-Ming Tsai; Irshad A Hajam; J R Caldera; George Y Liu
Journal:  Cell Chem Biol       Date:  2022-05-19       Impact factor: 9.039

4.  Murine Models for Staphylococcal Infection.

Authors:  Nathan Klopfenstein; James E Cassat; Andrew Monteith; Anderson Miller; Sydney Drury; Eric Skaar; C Henrique Serezani
Journal:  Curr Protoc       Date:  2021-03

5.  A Supramolecular Platform Technology for Bacterial Cell Surface Modification.

Authors:  Nikolas Duszenko; Danny M van Willigen; Mick M Welling; Clarize M de Korne; Roos van Schuijlenburg; Beatrice M F Winkel; Fijs W B van Leeuwen; Meta Roestenberg
Journal:  ACS Infect Dis       Date:  2020-05-15       Impact factor: 5.084

6.  Protease-Mediated Growth of Staphylococcus aureus on Host Proteins Is opp3 Dependent.

Authors:  McKenzie K Lehman; Austin S Nuxoll; Kelsey J Yamada; Tammy Kielian; Steven D Carson; Paul D Fey
Journal:  mBio       Date:  2019-04-30       Impact factor: 7.867

7.  Exoproteome Heterogeneity among Closely Related Staphylococcus aureus t437 Isolates and Possible Implications for Virulence.

Authors:  Xin Zhao; Laura M Palma Medina; Tim Stobernack; Corinna Glasner; Anne de Jong; Putri Utari; Rita Setroikromo; Wim J Quax; Andreas Otto; Dörte Becher; Girbe Buist; Jan Maarten van Dijl
Journal:  J Proteome Res       Date:  2019-06-05       Impact factor: 4.466

8.  Staphylococcus aureus Alpha-Toxin Limits Type 1 While Fostering Type 3 Immune Responses.

Authors:  Agnes Bonifacius; Oliver Goldmann; Stefan Floess; Silva Holtfreter; Philippe A Robert; Maria Nordengrün; Friederike Kruse; Matthias Lochner; Christine S Falk; Ingo Schmitz; Barbara M Bröker; Eva Medina; Jochen Huehn
Journal:  Front Immunol       Date:  2020-08-07       Impact factor: 7.561

9.  Reduced Production of Bacterial Membrane Vesicles Predicts Mortality in ST45/USA600 Methicillin-Resistant Staphylococcus aureus Bacteremia.

Authors:  Somrita Dey; Smitha Gudipati; Christopher Giuliano; Marcus J Zervos; Jonathan M Monk; Richard Szubin; Sarah C J Jorgensen; George Sakoulas; Andrew D Berti
Journal:  Antibiotics (Basel)       Date:  2019-12-18

10.  Peptidoglycan binding protein (PGBP)-modified magnetic nanobeads for efficient magnetic capturing of Staphylococcus aureus associated with sepsis in blood.

Authors:  Jaewoo Lim; Jongmin Choi; Kyeonghye Guk; Seong Uk Son; Do Kyung Lee; Soo-Jin Yeom; Taejoon Kang; Juyeon Jung; Eun-Kyung Lim
Journal:  Sci Rep       Date:  2019-01-15       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.